A 5-Year Comparison of Doxazosin and Atenolol in Patients With Mild-to-Moderate Hypertension: Effects on Blood Pressure, Serum Lipids, and Coronary Heart Disease Risk

By DAAE LUDVIG N. W.   WESTLIE LARS  

Blood Pressure, Vol. 7, Iss. 1, 1998-04 ,pp. : 39-45

Informa Healthcare

Access to resources Recommend Favorite

The association of serum chemerin level with risk of coronary artery disease in Chinese adults

By Yan Qun  

Endocrine, Vol. 41, Iss. 2, 2012-04 ,pp. : 281-288

Springer Publishing Company

Access to resources Recommend Favorite

Inflammation and Coronary Artery Disease

By  

Current Vascular Pharmacology, Vol. 1, Iss. 1, 2003-03 ,pp. : 65-70

Bentham Science Publishers

Access to resources Recommend Favorite

HIV, Metabolic Syndrome X, Inflammation, Oxidative Stress, and Coronary Heart Disease Risk : Role of Protease Inhibitor Exposure

By Hurwitz Barry E.   Klimas Nancy G.   Llabre Maria M.   Maher Kevin J.   Skyler Jay S.   Bilsker Martin S.   McPherson-Baker Shvawn   Lawrence Peter J.   LaPerriere Arthur R.   Greeson Jeffrey M.   Klaus Johanna R.   Lawrence Rasha   Schneiderman Neil  

Cardiovascular Toxicology, Vol. 4, Iss. 3, 2004-08 ,pp. : 303-316

Humana Press, Inc

Access to resources Recommend Favorite

Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study)

By Olkinuora Jyrki   Viikari Jorma   Vanhanen Hannu   Makkonen Niina   Kalliomäki Tero  

Scandinavian Cardiovascular Journal, Vol. 40, Iss. 3, 2006-06 ,pp. : 160-166

Informa Healthcare

Access to resources Recommend Favorite